{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:51:39Z","timestamp":1791571899350,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer incidence is increasing worldwide while survival remains poor. The incidence varies significantly across different regions. The aim of the present study was to analyse incidence, mortality and survival of patients diagnosed with pancreatic cancer in the canton of Zurich, Switzerland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Population-based cancer registry data and cause of death statistics of the canton of Zurich from 1981 to 2021 were analysed. Age-standardised incidence and mortality rates per 100\u2019000 person-years and net survival were calculated. Joinpoint regression analysis was conducted to identify significant changes in time trends while net survival was estimated using the Pohar-Perme method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age-standardised incidence rate of pancreatic adenocarcinomas (PAC) remained stable between 1981 and 2000 and then increased from 2000 to 2021, while pancreatic neuroendocrine tumours (PNET) incidence increased throughout and pancreatic cancers non histologically or cytologically confirmed (PC Non-HC) decreased. Overall age-standardised mortality rate remained stable. Five-year net survival was moderate for PNET (54.8%), but poor for PAC (4.8%) and PC Non-HC (1.2%). Among patients with PAC, survival declined with increasing age, earlier diagnosis year and advanced stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Over the past 40 years, PNET incidence slowly increased. In contrast, PAC incidence significantly increased within the last 20 years. The underlying causes of the observed increase in PAC incidence might be attributable to special risk factors, e.g. obesity, but other risk factors should also be considered. Mortality rates of pancreatic cancer were stable and net survival was poor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12029-026-01498-8","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:50:39Z","timestamp":1779969039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in Pancreatic Cancer Incidence, Mortality and Net Survival: A Population-Based Analysis in Zurich (Switzerland), 1981\u20132021"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-5061","authenticated-orcid":false,"given":"Linda","family":"Vinci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-0690","authenticated-orcid":false,"given":"Miriam","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2924-8080","authenticated-orcid":false,"given":"Andreas","family":"Wicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7986-2839","authenticated-orcid":false,"given":"Holger","family":"Moch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9217-8038","authenticated-orcid":false,"given":"Dimitri","family":"Korol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2215-1200","authenticated-orcid":false,"given":"Sabine","family":"Rohrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"3","key":"1498_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"1498_CR2","doi-asserted-by":"publisher","unstructured":"Bazeed AY, Day CM, Garg S. Pancreatic cancer: challenges and opportunities in locoregional therapies. Cancers. 2022;14(17). https:\/\/doi.org\/10.3390\/cancers14174257.","DOI":"10.3390\/cancers14174257"},{"issue":"4","key":"1498_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2468-1253(23)00039-0","volume":"8","author":"TLG Hepatology","year":"2023","unstructured":"Hepatology TLG. Cause for concern: the rising incidence of early-onset pancreatic cancer. Lancet Gastroenterol Hepatol. 2023;8(4):287. https:\/\/doi.org\/10.1016\/S2468-1253(23)00039-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"1498_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.5114\/aoms.2020.94845","volume":"16","author":"G Lippi","year":"2020","unstructured":"Lippi G, Mattiuzzi C. The global burden of pancreatic cancer. Arch Med Sci. 2020;16(4):820\u20134. https:\/\/doi.org\/10.5114\/aoms.2020.94845.","journal-title":"Arch Med Sci"},{"issue":"27","key":"1498_CR5","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","volume":"27","author":"JX Hu","year":"2021","unstructured":"Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27(27):4298\u2013321. https:\/\/doi.org\/10.3748\/wjg.v27.i27.4298.","journal-title":"World J Gastroenterol"},{"issue":"3 Pt 2","key":"1498_CR6","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.lpm.2019.02.030","volume":"48","author":"P Maisonneuve","year":"2019","unstructured":"Maisonneuve P. Epidemiology and burden of pancreatic cancer. Presse Med. 2019;48(3 Pt 2):e113\u201323. https:\/\/doi.org\/10.1016\/j.lpm.2019.02.030.","journal-title":"Presse Med"},{"issue":"1","key":"1498_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12029-025-01183-2","volume":"56","author":"PD Leiphrakpam","year":"2025","unstructured":"Leiphrakpam PD, Chowdhury S, Zhang M, Bajaj V, Dhir M, Are C. Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes. J Gastrointest Cancer. 2025;56(1):71. https:\/\/doi.org\/10.1007\/s12029-025-01183-2.","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"1498_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12885-025-13597-z","volume":"25","author":"T Li","year":"2025","unstructured":"Li T, Lin C, Wang W. Global, regional, and national burden of pancreatic cancer from 1990 to 2021, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021. BMC Cancer. 2025;25(1):189. https:\/\/doi.org\/10.1186\/s12885-025-13597-z.","journal-title":"BMC Cancer"},{"key":"1498_CR9","doi-asserted-by":"publisher","unstructured":"Partyka O, Pajewska M, Kwasniewska D, Czerw A, Deptala A, Budzik M, et al. Overview of pancreatic cancer epidemiology in Europe and recommendations for screening in high-risk populations. Cancers. 2023;15(14). https:\/\/doi.org\/10.3390\/cancers15143634.","DOI":"10.3390\/cancers15143634"},{"key":"1498_CR10","first-page":"328","volume":"4","author":"M Montemuro","year":"2013","unstructured":"Montemuro M, Lorez M. Trends in Pancreatic Cancer Survival in Switzerland. Schweizer Krebsbulletin. 2013;4:328\u201332.","journal-title":"Schweizer Krebsbulletin"},{"key":"1498_CR11","unstructured":"Boyle P, Parkin DM. Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ. 1991(95):126\u201358."},{"key":"1498_CR12","volume-title":"Cancer Incidence in Five Continents Volume III","author":"JC Waterhouse","year":"1976","unstructured":"Waterhouse JC, Muir P, Powell CS. J. Cancer Incidence in Five Continents Volume III. Lyon: IARC Scientific Publication No. 15; 1976."},{"issue":"1","key":"1498_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","volume":"68","author":"MP Perme","year":"2012","unstructured":"Perme MP, Stare J, Est\u00e8ve J. On Estimation in Relative Survival. Biometrics. 2012;68(1):113\u201320. https:\/\/doi.org\/10.1111\/j.1541-0420.2011.01640.x.","journal-title":"Biometrics"},{"key":"1498_CR14","unstructured":"National Agency for Cancer Registration. Your right to object. https:\/\/nkrs.ch\/en\/information-for-patients\/your-right-to-object. Accessed 16.01.2026."},{"key":"1498_CR15","doi-asserted-by":"publisher","unstructured":"Garcia-Velasco A, Zacarias-Pons L, Teixidor H, Valeros M, Linan R, Carmona-Garcia MC, et al. Incidence and survival trends of pancreatic cancer in Girona: impact of the change in patient care in the last 25 years. Int J Environ Res Public Health. 2020;17(24). https:\/\/doi.org\/10.3390\/ijerph17249538.","DOI":"10.3390\/ijerph17249538"},{"key":"1498_CR16","doi-asserted-by":"publisher","unstructured":"Zottl J, Sebesta CG, Tomosel E, Sebesta MC, Sebesta C. Unraveling the burden of pancreatic cancer in the 21st century: trends in incidence, mortality, survival, and key contributing factors. Cancers (Basel). 2025;17(10). https:\/\/doi.org\/10.3390\/cancers17101607.","DOI":"10.3390\/cancers17101607"},{"issue":"5","key":"1498_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.hoc.2022.07.002","volume":"36","author":"E Afghani","year":"2022","unstructured":"Afghani E, Klein AP. Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes. Hematol Oncol Clin North Am. 2022;36(5):879\u201395. https:\/\/doi.org\/10.1016\/j.hoc.2022.07.002.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"1498_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S2468-1253(19)30323-1","volume":"4","author":"AP Klein","year":"2019","unstructured":"Klein AP. Pancreatic cancer: a growing burden. Lancet Gastroenterol Hepatol. 2019;4(12):895\u20136. https:\/\/doi.org\/10.1016\/S2468-1253(19)30323-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"1498_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.hoc.2015.04.009","volume":"29","author":"RZ Stolzenberg-Solomon","year":"2015","unstructured":"Stolzenberg-Solomon RZ, Amundadottir LT. Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am. 2015;29(4):619\u201340. https:\/\/doi.org\/10.1016\/j.hoc.2015.04.009.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"1498_CR20","doi-asserted-by":"publisher","first-page":"pkaa033","DOI":"10.1093\/jncics\/pkaa033","volume":"4","author":"WL da Costa Jr","year":"2020","unstructured":"da Costa WL Jr., Oluyomi AO, Thrift AP. Trends in the Incidence of Pancreatic Adenocarcinoma in All 50 United States Examined Through an Age-Period-Cohort Analysis. JNCI Cancer Spectr. 2020;4(4):pkaa033. https:\/\/doi.org\/10.1093\/jncics\/pkaa033.","journal-title":"JNCI Cancer Spectr"},{"key":"1498_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2342-13-22","volume":"13","author":"A Aroua","year":"2013","unstructured":"Aroua A, Samara ET, Bochud FO, Meuli R, Verdun FR. Exposure of the Swiss population to computed tomography. BMC Med Imaging. 2013;13:22. https:\/\/doi.org\/10.1186\/1471-2342-13-22.","journal-title":"BMC Med Imaging"},{"issue":"3\u20134","key":"1498_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/rpd\/ncab012","volume":"195","author":"A Viry","year":"2021","unstructured":"Viry A, Bize J, Trueb PR, Ott B, Racine D, Verdun FR, et al. Annual Exposure of the Swiss Population from Medical Imaging in 2018. Radiat Prot Dosimetry. 2021;195(3\u20134):289\u201395. https:\/\/doi.org\/10.1093\/rpd\/ncab012.","journal-title":"Radiat Prot Dosimetry"},{"key":"1498_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2019.11.002","volume":"125","author":"AEJ Latenstein","year":"2020","unstructured":"Latenstein AEJ, van der Geest LGM, Bonsing BA, Groot Koerkamp B, Haj Mohammad N, de Hingh I, et al. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer. 2020;125:83\u201393. https:\/\/doi.org\/10.1016\/j.ejca.2019.11.002.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1498_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s12885-018-4610-4","volume":"18","author":"AM Saad","year":"2018","unstructured":"Saad AM, Turk T, Al-Husseini MJ, Abdel-Rahman O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer. 2018;18(1):688. https:\/\/doi.org\/10.1186\/s12885-018-4610-4.","journal-title":"BMC Cancer"},{"key":"1498_CR25","doi-asserted-by":"publisher","unstructured":"Ushio J, Kanno A, Ikeda E, Ando K, Nagai H, Miwata T, et al. Pancreatic ductal adenocarcinoma: epidemiology and risk factors. Diagnostics (Basel). 2021;11(3). https:\/\/doi.org\/10.3390\/diagnostics11030562.","DOI":"10.3390\/diagnostics11030562"},{"key":"1498_CR26","doi-asserted-by":"publisher","unstructured":"Jiang Y, Abboud Y, Liang J, Larson B, Osipov A, Gong J, et al. The disproportionate rise in pancreatic cancer in younger women is due to a rise in adenocarcinoma and not neuroendocrine tumors: a nationwide time-trend analysis using 2001\u20132018 United States cancer statistics databases. Cancers (Basel). 2024;16(5). https:\/\/doi.org\/10.3390\/cancers16050971.","DOI":"10.3390\/cancers16050971"},{"issue":"4","key":"1498_CR27","doi-asserted-by":"publisher","first-page":"e254682","DOI":"10.1001\/jamanetworkopen.2025.4682","volume":"8","author":"A Bussetty","year":"2025","unstructured":"Bussetty A, Shen J, Benias PC, Ma M, Stewart M, Trindade AJ. Incidence of Pancreas and Colorectal Adenocarcinoma in the US. JAMA Netw Open. 2025;8(4):e254682. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.4682.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1498_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pan.2023.12.005","volume":"24","author":"SS Dahia","year":"2024","unstructured":"Dahia SS, Konduru L, Pandol SJ, Barreto SG. The burden of young-onset pancreatic cancer and its risk factors from 1990 to 2019: A systematic analysis of the global burden of disease study 2019. Pancreatology. 2024;24(1):119\u201329. https:\/\/doi.org\/10.1016\/j.pan.2023.12.005.","journal-title":"Pancreatology"},{"key":"1498_CR29","unstructured":"Federal Office of Public Health. Tabak. 2025. https:\/\/www.bfs.admin.ch\/bfs\/de\/home\/statistiken\/gesundheit\/determinanten\/tabak.html.\u00a0 Accessed 17.10.2025."},{"issue":"1Suppl 1","key":"1498_CR30","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/bjc.2012.116","volume":"107","author":"R Bevan","year":"2012","unstructured":"Bevan R, Young C, Holmes P, Fortunato L, Slack R, Rushton L, et al. Occupational cancer in Britain. Gastrointestinal cancers: liver, oesophagus, pancreas and stomach. Br J Cancer. 2012;107(1Suppl 1):S33\u201340. https:\/\/doi.org\/10.1038\/bjc.2012.116.","journal-title":"Br J Cancer"},{"issue":"32","key":"1498_CR31","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.3748\/wjg.v28.i32.4698","volume":"28","author":"I Ilic","year":"2022","unstructured":"Ilic I, Ilic M. International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis. World J Gastroenterol. 2022;28(32):4698\u2013715. https:\/\/doi.org\/10.3748\/wjg.v28.i32.4698.","journal-title":"World J Gastroenterol"},{"key":"1498_CR32","doi-asserted-by":"publisher","unstructured":"Kavaliauskas P, Dulskas A, Kildusiene I, Arlauskas R, Stukas R, Smailyte G. Trends in pancreatic cancer incidence and mortality in Lithuania, 1998\u20132015. Int J Environ Res Public Health. 2022;19(2). https:\/\/doi.org\/10.3390\/ijerph19020949.","DOI":"10.3390\/ijerph19020949"},{"key":"1498_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000981","author":"C Santucci","year":"2025","unstructured":"Santucci C, Bertuccio P, Mignozzi S, Pizzato M, Corso G, Odone A, et al. Cancer mortality in Europe in 2020, and an overview of trends since 1990. Eur J Cancer Prev. 2025. https:\/\/doi.org\/10.1097\/CEJ.0000000000000981.","journal-title":"Eur J Cancer Prev"},{"key":"1498_CR34","doi-asserted-by":"publisher","first-page":"102204","DOI":"10.1016\/j.canep.2022.102204","volume":"79","author":"A Stang","year":"2022","unstructured":"Stang A, Wellmann I, Holleczek B, Fell B, Terner S, Lutz MP, et al. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009\u20132018. An in-depth analysis of two population-based cancer registries. Cancer Epidemiol. 2022;79:102204. https:\/\/doi.org\/10.1016\/j.canep.2022.102204.","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"1498_CR35","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1007\/s12094-024-03484-7","volume":"26","author":"AQK Yasinzai","year":"2024","unstructured":"Yasinzai AQK, Tareen B, Tracy K, Jamil N, Khan M, Ullah H, et al. Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study. Clin Transl Oncol. 2024;26(10):2618\u201328. https:\/\/doi.org\/10.1007\/s12094-024-03484-7.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"1498_CR36","doi-asserted-by":"publisher","first-page":"16425","DOI":"10.1038\/s41598-020-73525-y","volume":"10","author":"A Bengtsson","year":"2020","unstructured":"Bengtsson A, Andersson R, Ansari D. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data. Sci Rep. 2020;10(1):16425. https:\/\/doi.org\/10.1038\/s41598-020-73525-y.","journal-title":"Sci Rep"},{"key":"1498_CR37","doi-asserted-by":"publisher","first-page":"7656197","DOI":"10.1155\/2018\/7656197","volume":"2018","author":"M Wanner","year":"2018","unstructured":"Wanner M, Matthes KL, Korol D, Dehler S, Rohrmann S. Indicators of Data Quality at the Cancer Registry Zurich and Zug in Switzerland. Biomed Res Int. 2018;2018:7656197. https:\/\/doi.org\/10.1155\/2018\/7656197.","journal-title":"Biomed Res Int"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01498-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01498-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01498-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:08:37Z","timestamp":1791569317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01498-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01498-8","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was originally published under the subscription model but it is now published under an Open Access license.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki (as revised in 2013). In accordance with the Swiss law on human research, approval from an ethics committee was not required because the data were anonymized.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Cancer cases in the Canton of Zurich are registered with presumed consent and registration based on a decision by the Zurich Government Council from 1980 and the general registry approval by the Federal Commission of Experts for professional secrecy in medical research from 1995.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"129"}}